S. Hua
Biomaterials · 2015–2018
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Biomaterials — 25 citations into it
- Molecular Biology — 24 citations into it
Whom S. Hua trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from S. Hua's perspective
Ordered by how strongly the researchers S. Hua trusts endorse each paper. Same corpus, a different order for every researcher.
- Drug Delivery Systems: Entering the Mainstream (Science)
- Openings between defective endothelial cells explain tumor vessel leakiness. (American Journal of Pathology)
- Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. (Journal of Controlled Release)
- Nanoparticles in Medicine: Therapeutic Applications and Developments (Clinical pharmacology and therapy)
- EPR: Evidence and fallacy. (Journal of Controlled Release)
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. (Advanced Drug Delivery Reviews)
- To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? (Journal of Controlled Release)
- Toxicity of cationic lipids and cationic polymers in gene delivery. (Journal of Controlled Release)
- Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. (Progress in lipid research)
- Multifunctional nanocarriers. (Advanced Drug Delivery Reviews)